Research

News & Research
SUBSCRIBE TO OUR NEWSLETTER
October 2022
Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity
Read more
February 2022
Models of Psychedelic Drug Action: Modulation of Cortical-Subcortical Circuits
Read more
September 2021
Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems
Read more
October 2017
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Read more
Our Mission
The Psychedelic Medicine Coalition (PMC) is a DC-based, multi-industry 501(C)6 organization with the mission to improve the commercial and regulatory space for novel and alternative treatments to mental health affiliations.
Get in Touch
Contact Us
AdvocacyLeadershipMembersPsychedelic Vote
ResearchNewsDonate